疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

6 G- p( K/ ?" B! ?3 e& KApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

0 j5 s: l/ M( g: dhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
- T( G$ r9 l) P. @  o$ h3 V2 Vaccine immunology 14
6 Z4 ]7 e9 {6 k8 H  ]3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
+ D. H7 w2 q8 Q6 u- e: |licensed vaccines 71
6 Z, i( |9 }# J" H7 ]7 k2 A0 Z7 Passive immunization 80
8 General immunization practices 88
7 W5 j" d( a. N% X* pSECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
- M* m0 I4 D. t3 j  \12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
  W- V& ]' A, R/ s15 Hepatitis B vaccines 205
7 X4 a" W8 `/ p9 Q! m" K16 Human papillomavirus vaccines 235
: D, {$ k- W; e8 Z8 Z. H1 H( _17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
9 Z) Z% |# a8 k2 B- w20 Measles vaccines 352
8 t2 s9 W% _( _* P21 Meningococcal vaccines 388
22 Mumps vaccine 419
, X& y, ~& |9 h, |23 Pertussis vaccines . 447
5 v5 k$ ?. S" ~24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
* W# J- M, d( W26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
) h4 |7 t1 d) O* G% w1 h* j28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
/ ^" ?: o( J6 J& p6 l: ?30 Rotavirus vaccines . 669
4 q& F7 {2 F0 I# s31 Rubella vaccine 688
2 A* R) S6 H- V* `3 L- D, X5 o32 Smallpox and vaccinia 718
; [! a: V, c% U# S# h) r9 U33 Tetanus toxoid 746
5 P: c) ?3 m; E4 |4 Y% ?' A6 p34 Tick-borne encephalitis virus vaccines 773
+ O$ S3 l, i2 I& j* C2 o35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
, `" h$ I# ]. y) H% ESECTION 3: Vaccines in development and new vaccine strategies
" K0 p  J* x1 E, C41 Biodefense and special pathogen vaccines 1008
! d' ?1 ^, x9 g' o4 _/ R# c  b+ D42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
9 R5 e# _/ [- n3 f. J; O2 c+ b0 {+ q44 Dengue vaccines 1042
$ T  H6 j2 f$ G" h  Q45 Diarrhea caused by bacteria 1052
9 @6 G8 H- d6 p* i) E  M46 Ebola vaccine 1060
% Y% g  I" Z: Y! q/ E47 Epstein-Barr virus vaccines 1068
  J! R, Z3 g0 G. N8 A3 r# r3 s9 o48 Hepatitis C vaccines 1074
; c3 v" a1 O4 m49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
" h# Z5 E8 N1 P6 \* O2 P" d53 Malaria vaccines 1133
, J# b5 J* N2 N54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
. _& i3 Z- B' g2 w$ F+ l56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
! b9 [8 b" z% Y) X+ U7 \58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
; n. V: e, R/ j4 K60 Technologies for making new vaccines 1182
+ p8 Z* a6 Y3 d% i+ l61 Alternative vaccine delivery methods 1200
. i; R8 x' k0 O5 U& J- a( g62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
3 L! B8 u" x1 S. l6 |63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
( J* w7 O1 b$ e1 D# ]; d* X65 Vaccines for international travel 1270
2 }: @6 P/ ], `0 a# h- D5 H+ V66 Vaccines for health care personnel 1290
0 N! @* b6 q: x- H, z' f4 N& d3 n5 RSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
2 A* ~, X$ X7 p( v: k3 h72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
) ~' f) i: J& f77 Legal issues . 1481
2 t6 b' J0 P- ~7 ]  \, Q. W) U78 Ethics 1508

' L/ {9 {) O( C& W  c' g0 Y5 b8 |
' u  \- D/ `+ \

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition
* v  K2 P, h6 y$ z6 O% S
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

3 L0 ^! Q8 D6 ~4 }0 f. `( K2 @& w2 Hhttp://yun.baidu.com/share/link? ... 1&uk=3810996606
% L* t0 V/ V- {$ \: [4 c2 v! @
7 I7 b- ?9 C7 E+ F; ~/ ^SECTION 1: General aspects of vaccination
; Y/ W1 a! n# I9 o1 A short history of vaccination 1
6 @1 S0 `& W7 I( r2 Vaccine immunology 14
- d- F; H/ P# ?- [4 j3 H3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
0 a* e  v9 ^) V( I+ b: c7 Passive immunization 80
2 H# ?; t' }- c* A5 \8 General immunization practices 88
+ ], D% r) b& U  f* |4 ESECTION 2: Licensed vaccines
+ Y9 Q: P' D. U" X. W4 y9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
+ }/ ?/ Q  L8 I/ q2 _12 Diphtheria toxoid 153
! ~0 e7 W' g3 ]% `/ b13 Haemophilus influenzae vaccines 167
' m/ ?3 [9 o: F: Q- K- O14 Hepatitis A vaccines 183
, ~/ l. H  W& a7 _15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
6 w4 Z8 z( X$ z$ l$ ]" F; [4 \17 Inactivated influenza vaccines 257
) d9 S3 ?7 m* ]% N18 Influenza vaccine-live 294
1 s/ _, n7 k, R) _* U19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
+ M6 J# ?: |* ~8 C2 O( ?21 Meningococcal vaccines 388
22 Mumps vaccine 419
9 j# c- r7 U% R' _: C, i8 X' `1 p23 Pertussis vaccines . 447
% k' @8 V! ^" |9 }- f4 _3 z4 v; B- ?# x24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
+ x: r, T4 A3 B, H8 h2 q$ `7 R26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
! H: D6 b2 K! o5 r/ P31 Rubella vaccine 688
5 r3 J  d, ~' J# q32 Smallpox and vaccinia 718
. N. R. ^! D1 x: T6 |8 F33 Tetanus toxoid 746
3 l' D# m. W1 v1 C8 M34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
7 A. s5 S. j( w36 Typhoid fever vaccines 812
- |* l6 n, g* w37 Varicella vaccine 837
38 Yellow fever vaccine 870
  n0 ?% e  a1 e2 m/ s$ ]39 Zoster vaccine 969
40 Combination vaccines 981
% J+ ]5 k( z) L/ ZSECTION 3: Vaccines in development and new vaccine strategies
8 j. [- x* o0 F41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
$ S+ G2 w1 V2 H% g/ L; t' T! C( \43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
- h8 G# H( i, Q7 |1 G7 l45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
0 H4 A" j: n" T9 q* t47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
0 D- W: q' m9 u3 {3 D/ `, L- y" b50 Herpes simplex virus vaccines 1090
4 m8 x9 `) ]% I0 w& U: r51 Human immunodeficiency virus vaccines 1097
9 N# X* |  [3 A# K2 z4 w( x52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
$ ^  x. \) Y1 [* o4 D8 J: C3 R58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
' R1 z7 W" K" F9 n# @65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
' ^1 q1 z/ ?" ^4 d: u7 Z3 T69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
4 ^/ g8 p( A/ @$ R8 }  X6 p71 Community immunity 1395
2 B: @& n8 |! N) i+ B72 Economic analyses of vaccine policies 1413
1 S8 h! k) l* l0 y' z/ I73 Regulation and testing of vaccines 1427
  g! c1 s1 S- j& `74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
" }% }; C' p- z& a9 \9 w8 n77 Legal issues . 1481
78 Ethics 1508

- v3 _# o5 {  I. n4 ?1 Y/ q  p

casarett

Vaccines, 6e, 2012

Hardcover: 1570 pages
7 J2 b8 l4 C. H9 ~1 t9 ~% lPublisher: Saunders; 6 edition (October 30, 2012)
+ O' \; J1 Z- m7 `Language: English
' p7 K% l) W0 K- J& [7 y- PISBN-10: 1455700908
Size: 52.3mb (original pdf)
1 r/ m7 U7 k5 W! c* S7 `
2013 BMA Medical Book Awards Highly Commended in Public Health!
6 H6 U* C5 F( ?  k0 JApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

# x% h  b- i* r3 xGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
# r1 Z$ c. Z% {Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
! N" y7 p  D0 T: n) S' uAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
) [$ j$ _/ c6 B* x; M4 YClearly visualize concepts and objective data through an abundance of tables and figures.
0 s1 N% D- m* A6 J, bPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
9 }( U8 i3 B9 p4 K; gMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
! c" e; I% W3 g
  ?" P& s% c( U# PDownload link: http://pan.baidu.com/s/1i5NxwLR
% o$ ^: T% k$ nCode for downloading: dv96